Haemonetics Corp. (HAE) Misses Q2 EPS Views; Affirms Outlook

August 1, 2011 8:01 AM EDT
Get Alerts HAE Hot Sheet
Price: $90.80 --0%

Financial Fact:
Net revenues: 220.25M

Today's EPS Names:
VISL, GNLN, USDP, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q2 EPS of $0.65, $0.13 worse than the analyst estimate of $0.78. Revenue for the quarter came in at $170.6 million versus the consensus estimate of $170.4 million.

Affirms outlook.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance